Intriguingly, the results from one study indicated that elevated levels of plasma prolactin were associated with an increased risk of breast cancer in situ17, whereas the other 6 studies reported no such correlation10, 12, 13, 14, 15, 16. This evidence concerns the gene PRL and breast cancer.